Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Non-coding RNA regulation of RIPK1 in necroptosis
FY 2020-21
Summary
Background: Atherosclerosis is a common cardiovascular condition where blood flow can be restricted by lipid and immune cell buildup inside arteries. Necroptosis, a programmed form of cell death, is activated during atherosclerosis. As a critical mediator of the necroptotic pathway, receptor-interacting protein kinase 1 (RIPK1) helps to determine whether a cell survives or dies. These pathological processes can be controlled by microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), which show dysregulation in diseases including atherosclerosis. Rationale: While existing research reveals elevated RIPK1 activity in atherosclerotic plaques, it remains unclear how RIPK1 is regulated at the RNA level. Our project aims to fill this gap by highlighting key non-coding (ncRNAs) that interact with Ripk1 messenger RNA (mRNA). Hypothesis: Distinct miRNAs and lncRNAs regulate RIPK1 expression in macrophages, which in turn influences RIPK1 activity in necroptosis during atherosclerosis. Methods: We will be using mouse macrophages and adding specific stimuli to create a necroptotic environment. Pull-down assays will be performed to identify miRNAs and lncRNAs binding Ripk1 mRNA, and RNA sequencing will allow us to analyze their expression. With miRNA mimics and lncRNA vectors, we will overexpress sequences of interest in treated cells. Other molecular biology techniques will also be used to examine the presence of inflammatory and cell death markers. Significance: This research will broaden our knowledge of mechanisms that drive macrophage necroptosis in vulnerable plaques, paving the way for future analyses and applications in vivo. Our findings may potentially lead to the development of targeted therapies for advanced atherosclerosis, reducing the global burden of disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449790
Name
Zhou Zier
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Non-coding RNA regulation of RIPK1 in necroptosis
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Cell Death; Inflammation; Long Non-Coding Rnas; Macrophages; Micrornas; Necroptosis; Non-Coding Rnas; Proteins; Ripk1
Abstract
Background: Atherosclerosis is a common cardiovascular condition where blood flow can be restricted by lipid and immune cell buildup inside arteries. Necroptosis, a programmed form of cell death, is activated during atherosclerosis. As a critical mediator of the necroptotic pathway, receptor-interacting protein kinase 1 (RIPK1) helps to determine whether a cell survives or dies. These pathological processes can be controlled by microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), which show dysregulation in diseases including atherosclerosis. Rationale: While existing research reveals elevated RIPK1 activity in atherosclerotic plaques, it remains unclear how RIPK1 is regulated at the RNA level. Our project aims to fill this gap by highlighting key non-coding (ncRNAs) that interact with Ripk1 messenger RNA (mRNA). Hypothesis: Distinct miRNAs and lncRNAs regulate RIPK1 expression in macrophages, which in turn influences RIPK1 activity in necroptosis during atherosclerosis. Methods: We will be using mouse macrophages and adding specific stimuli to create a necroptotic environment. Pull-down assays will be performed to identify miRNAs and lncRNAs binding Ripk1 mRNA, and RNA sequencing will allow us to analyze their expression. With miRNA mimics and lncRNA vectors, we will overexpress sequences of interest in treated cells. Other molecular biology techniques will also be used to examine the presence of inflammatory and cell death markers. Significance: This research will broaden our knowledge of mechanisms that drive macrophage necroptosis in vulnerable plaques, paving the way for future analyses and applications in vivo. Our findings may potentially lead to the development of targeted therapies for advanced atherosclerosis, reducing the global burden of disease.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhou, Zier
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~